Customize your JAMA Network experience by selecting one or more topics from the list below.
Annema JT, van Meerbeeck JP, Rintoul RC, et al. Mediastinoscopy vs Endosonography for Mediastinal Nodal Staging of Lung Cancer: A Randomized Trial. JAMA. 2010;304(20):2245–2252. doi:10.1001/jama.2010.1705
Author Affiliations: Departments of Pulmonology (Drs Annema and Rabe); Clinical Epidemiology, Endocrinology, and Metabolic Diseases (Dr Dekkers); Cardio-Thoracic Surgery (Drs Braun and Versteegh); and Pathology (Dr Veseliç), Leiden University Medical Center, Leiden, the Netherlands; Lung Oncology Network (Drs van Meerbeeck, Praet, de Ryck, Vermassen, and Tournoy) and Department of Biostatistics (Dr Deschepper), Ghent University Hospital, Ghent, Belgium; Department of Thoracic Oncology, Papworth Hospital, Cambridge, United Kingdom (Drs Rintoul and Carroll); Departments of Pulmonology (Drs Dooms and Vansteenkiste) and Surgery (Dr De Leyn), Leuven University Hospitals, Leuven, Belgium; Department of Histopathology, Royal Brompton Hospital, Harefield Hospital, and National Heart and Lung Division, Imperial College School of Medicine, London, United Kingdom (Dr Nicholson).
Context Mediastinal nodal staging is recommended for patients with resectable non–small cell lung cancer (NSCLC). Surgical staging has limitations, which results in the performance of unnecessary thoracotomies. Current guidelines acknowledge minimally invasive endosonography followed by surgical staging (if no nodal metastases are found by endosonography) as an alternative to immediate surgical staging.
Objective To compare the 2 recommended lung cancer staging strategies.
Design, Setting, and Patients Randomized controlled multicenter trial (Ghent, Leiden, Leuven, Papworth) conducted between February 2007 and April 2009 in 241 patients with resectable (suspected) NSCLC in whom mediastinal staging was indicated based on computed or positron emission tomography.
Intervention Either surgical staging or endosonography (combined transesophageal and endobronchial ultrasound [EUS-FNA and EBUS-TBNA]) followed by surgical staging in case no nodal metastases were found at endosonography. Thoracotomy with lymph node dissection was performed when there was no evidence of mediastinal tumor spread.
Main Outcome Measures The primary outcome was sensitivity for mediastinal nodal (N2/N3) metastases. The reference standard was surgical pathological staging. Secondary outcomes were rates of unnecessary thoracotomy and complications.
Results Two hundred forty-one patients were randomized, 118 to surgical staging and 123 to endosonography, of whom 65 also underwent surgical staging. Nodal metastases were found in 41 patients (35%; 95% confidence interval [CI], 27%-44%) by surgical staging vs 56 patients (46%; 95% CI, 37%-54%) by endosonography (P = .11) and in 62 patients (50%; 95% CI, 42%-59%) by endosonography followed by surgical staging (P = .02). This corresponded to sensitivities of 79% (41/52; 95% CI, 66%-88%) vs 85% (56/66; 95% CI, 74%-92%) (P = .47) and 94% (62/66; 95% CI, 85%-98%) (P = .02). Thoracotomy was unnecessary in 21 patients (18%; 95% CI, 12%-26%) in the mediastinoscopy group vs 9 (7%; 95% CI, 4%-13%) in the endosonography group (P = .02). The complication rate was similar in both groups.
Conclusions Among patients with (suspected) NSCLC, a staging strategy combining endosonography and surgical staging compared with surgical staging alone resulted in greater sensitivity for mediastinal nodal metastases and fewer unnecessary thoracotomies.
Trial Registration clinicaltrials.gov Identifier: NCT00432640
Create a personal account or sign in to: